Yaopharma Co., Ltd.
-
Founded in:
1997-07-21 -
Country:
China -
Address:
No. 100, Xingguang Avenue, Renhe Town, Yubei District, Chongqing -
Tax NO.:
91500000202851807X -
Registered Funds:
196.54 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium gluconate |
|
527-07-1 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Paracetamol and pseudoephedrine |
No specific pharmacological information is available yet
More
No specific pharmacological information is available yet |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Arginine hydrochloride |
This product participates in the ornithine cycle in the human body, promotes the formation of urea, and converts the ammonia produced in the human body into non-toxic urea through the ornithine cycle and is excreted in the urine, thereby reducing blood ammonia concentration.
More
This product participates in the ornithine cycle in the human body, promotes the formation of urea, and converts the ammonia produced in the human body into non-toxic urea through the ornithine cycle and is excreted in the urine, thereby reducing blood ammonia concentration. |
1119-34-2 | 26 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gatifloxacin |
Gatifloxacin is a racemic compound of 8-methoxyfluoroquinolone, which has a broad spectrum of activity against Gram-negative and Gram-positive microorganisms in vitro. Its R- and S-enantiomers have the same antibacterial activity. The antibacterial effect of this product is through inhibiting bacterial DNA gyrase and topoisomerase IV, thereby inhibiting bacterial DNA replication, transcription and repair processes. It has antibacterial activity against most strains of the following microorganisms: 1 Gram-positive bacteria: Staphylococcus aureus (limited to strains sensitive to methicillin), Streptococcus pneumoniae (strains sensitive to penicillin). 2 Gram-negative bacteria: Escherichia coli, Haemophilus influenzae and parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Neisseria gonorrhoeae, Proteus mirabilis. 3 Other microorganisms: Chlamydia pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae.
More
Gatifloxacin is a racemic compound of 8-methoxyfluoroquinolone, which has a broad spectrum of activity against Gram-negative and Gram-positive microorganisms in vitro. Its R- and S-enantiomers have the same antibacterial activity. The antibacterial effect of this product is through inhibiting bacterial DNA gyrase and topoisomerase IV, thereby inhibiting bacterial DNA replication, transcription and repair processes. It has antibacterial activity against most strains of the following microorganisms: 1 Gram-positive bacteria: Staphylococcus aureus (limited to strains sensitive to methicillin), Streptococcus pneumoniae (strains sensitive to penicillin). 2 Gram-negative bacteria: Escherichia coli, Haemophilus influenzae and parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Neisseria gonorrhoeae, Proteus mirabilis. 3 Other microorganisms: Chlamydia pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae. |
112811-59-3 | 20 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium ferulic |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
24276-84-4 | 8 |